The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Guest Editorial

In support of three coordinated CCSG components reducing our national burden of cancer

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
BYLINEDOWNLOAD PDFTABLE OF CONTENTS

As we are all aware, the new presidential administration is moving rapidly to change how science, including health sciences, will be conducted and funded by the federal government, including research supported by the National Institutes of Health. 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Byline
Shine Chang, PhD
Ashbel Smith Professor & University of Texas System Distinguished Teaching Professor, Department of Health Disparities Research, Director, Cancer Prevention Research Training Program, Division of Cancer Prevention & Population Sciences, The University of Texas MD Anderson Cancer Center
Michaela A. Dinan, PhD
Associate professor, Department of Epidemiology Chronic Disease, Yale School of Public Health, Associate cancer center director, Cancer Research Education and Training, Co-leader, Cancer Prevention and Control Program, Yale Cancer Center, Co-director, Cancer Outcomes, Public Policy & Effectiveness Research (COPPER) Center, Yale School of Medicine
Miria Kano, PhD
Morton Cohen Cancer Center Endowed Chair, Associate professor of community & behavioral health, Colorado School of Public Health, CU Anschutz Medical Campus, Associate Director, Engagement, Access & Success, CU Cancer Center 
Table of Contents

YOU MAY BE INTERESTED IN

Guest Editorial

Federal funding cutbacks undermine advances in cancer research and treatment
What would Richard Nixon and Ted Kennedy think?

What did President Richard M. Nixon and Senator Edward M. Kennedy have in common? They each played a pivotal role in the passage of the National Cancer Act signed by Nixon on Dec. 23, 1971. The NCA established the National Cancer Program authorizing the initial investment in the NCI-designated Cancer Centers Program. 
By Donald L. "Skip" Trump and Eric T. Rosenthal
PodcastThe Directors

The Directors: Candace Johnson and Jonathan Friedberg on living through uncertainty at NCI, payment woes
Directors of two neighboring cancer centers in Upstate New York will face challenges, but “we’ll get through it”

Candace S. Johnson leads America’s oldest cancer research center and Jonathan W. Friedberg leads the newest NCI-designated center. Their catchment areas are contiguous, their faculty and staff members collaborate often, and together their institutions embody the culture of NCI-designated cancer centers. 
By Paul Goldberg
Byline
Shine Chang, PhD
Ashbel Smith Professor & University of Texas System Distinguished Teaching Professor, Department of Health Disparities Research, Director, Cancer Prevention Research Training Program, Division of Cancer Prevention & Population Sciences, The University of Texas MD Anderson Cancer Center
Michaela A. Dinan, PhD
Associate professor, Department of Epidemiology Chronic Disease, Yale School of Public Health, Associate cancer center director, Cancer Research Education and Training, Co-leader, Cancer Prevention and Control Program, Yale Cancer Center, Co-director, Cancer Outcomes, Public Policy & Effectiveness Research (COPPER) Center, Yale School of Medicine
Miria Kano, PhD
Morton Cohen Cancer Center Endowed Chair, Associate professor of community & behavioral health, Colorado School of Public Health, CU Anschutz Medical Campus, Associate Director, Engagement, Access & Success, CU Cancer Center 
Table of Contents

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account